Skip to content
StockMarketAgent
Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

LON/0RV2 stock hub

LON/0RV2 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

LON/0RV2is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
2.2B
London Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
LON/0RV2
In the news

Latest news · LON/0RV2

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/E27.2
P25 n/aP50 n/aP75 n/a
ROE71.4
P25 n/aP50 n/aP75 n/a
ROIC57.8
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All LON/0RV2 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
182
Groups with data
11
Currency
SEK
Showing 182 of 182 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
Sweden
Country code
UK
Employees
129
Employees Change
18%
Employees Change Percent
17.31
Enterprise value
SEK 2.1B
Exchange
London Stock Exchange
Financial currency
SEK
First seen
2026-05-10
Industry
Biological Products, Except Diagnostic Substances
Last refreshed
2026-05-10
Market cap
SEK 2.2B
Price
SEK 316
Price currency
SEK
Rev Per Employee
1,249,207.67x
Sic
2836
Symbol
lon/0RV2
Website
https://www.bioarctic.se

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

11
MetricValue
Earnings Yield
3.68%
EV Earnings
25.13x
EV/EBIT
19.03x
EV/EBITDA
18.82x
EV/FCF
18.08x
EV/Sales
13.02x
FCF yield
5.11%
P/B ratio
14.14x
P/E ratio
27.21x
P/S ratio
13.91x
PE Ratio3 Y
55.74x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

18
MetricValue
EBIT Margin
68.44%
FCF margin
71.07%
Gross margin
97.04%
Gross Profit
SEK 156.4M
Gross Profit Growth
742.09%
Gross Profit Growth Q
89.04%
Gross Profit Growth3 Y
132.12%
Gross Profit Growth5 Y
164.57%
Net Income
SEK 82.4M
Pretax Margin
62.81%
Profit Margin
51.14%
Profit Per Employee
SEK 638,831
ROA
46.39
Roa5y
8.01
ROCE
66.6
ROE
71.44
Roe5y
12.53
ROIC
57.77

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

7
MetricValue
Cagr1y
70.35%
Cagr3y
3.59%
Cagr5y
30.78%
Revenue Growth
676.8x
Revenue Growth Q
81.79x
Revenue Growth3 Y
105.78x
Revenue Growth5 Y
98.29x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
SEK 1.08
Assets
SEK 207.6M
Cash
SEK 176.6M
Current Assets
SEK 197.9M
Current Liabilities
SEK 41.5M
Debt
SEK 3.6M
Debt EBITDA
SEK 0.03
Debt Equity
SEK 0.02
Debt FCF
SEK 0.03
Equity
SEK 158.6M
Interest Coverage
675.3
Liabilities
SEK 49M
Long Term Assets
SEK 9.6M
Long Term Liabilities
SEK 7.6M
Net Cash
SEK 173M
Net Cash By Market Cap
SEK 7.72
Net Cash Growth
196.18%
Net Debt Equity
SEK -1.09
Net Debt FCF
SEK -1.51
Tangible Book Value
SEK 158.6M
Tangible Book Value Per Share
SEK 1.79
WACC
-0.02

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
4.78
Net Working Capital
SEK -16.8M
Quick ratio
4.76
Working Capital
SEK 158.5M
Working Capital Turnover
SEK 0.12

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

3
MetricValue
Buyback Yield
-0.23%
Dividend per share
SEK 0
Last Dividend
SEK 0.12

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

35
MetricValue
1Y total return
70.29%
200-day SMA
296.9
3Y total return
11.16%
50-day SMA
317
50-day SMA vs 200-day SMA
50over200
5Y total return
282.54%
All Time High
391
All Time High Change
-19.09%
All Time High Date
2023-06-12
All Time Low
2.87
All Time Low Change
10,922.9%
All Time Low Date
2018-01-22
ATR
12.1
Beta
-0.78
Ch YTD
1.29
High
320.2
High52
364.4
High52 Date
2026-02-18
High52ch
-13.18%
Low
314.4
Low52
165.8
Low52 Date
2025-05-12
Low52ch
90.81%
Ma50ch
-0.19%
Price vs 200-day SMA
6.55%
RSI
46.54
RSI Monthly
61.28
RSI Weekly
53.95
Sharpe ratio
1.21x
Sortino ratio
2.14
Total Return
-0.23%
Tr YTD
1.29
Tr1m
0.43%
Tr1w
-3.32%
Tr3m
3.86%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
SEK 110.3M
Operating margin
68.44

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
54,395,820%
Net Borrowing
70,838.6
Shares Insiders
32.2%
Shares Institutions
43.69%
Shares Qo Q
0.06%
Shares Yo Y
0.23%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

55
MetricValue
Adjusted FCF
SEK 112.6M
Average Volume
8,704.85x
Bv Per Share
1.79
CAPEX
SEK -825,685
Ch1m
0.43
Ch1w
-3.32
Ch1y
70.29
Ch3m
3.86
Ch3y
11.16
Ch5y
282.5
Ch6m
18.1
Change
-4.94%
Change From Open
-1.78
Close
332.8
Days Gap
-3.22
Depreciation Amortization
1,210,226.1
Dollar Volume
3,164,520.4
Earnings Date
2026-04-21
EBIT
SEK 110.3M
EPS
SEK 0.93
F Score
6
FCF
SEK 114.5M
FCF EV Yield
5.53x
Financing CF
2,168,724
Fiscal Year End
December
Founded
2,000
Graham Number
76.5099
Graham Upside
-75.82
Income Tax
SEK 18.8M
Investing CF
-72,117,250
Is Primary Listing
0
Last Earnings Date
2026-04-21
Last Report Date
2025-12-31
Ma150
310.8
Ma150ch
1.79%
Ma20
324.3
Ma20ch
-2.45%
Net CF
42,521,872
Next Earnings Date
2026-05-15
Open
322.1
P FCF Ratio
19.58
P OCF Ratio
19.44
Position In Range
33.74
Ppne
6,605,024.7
Price Date
2026-05-08
Ptbv Ratio
14.14
Relative Volume
1.21x
Revenue
161,147,790x
SBC By Revenue
1.2x
Share Based Comp
1,938,180
Tax By Revenue
11.67x
Tax Rate
18.58%
Tr6m
18.1%
Volume
10,003
Z Score
24.72
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does LON/0RV2 pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0RV2 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+70.3%
S&P 500 1Y: n/a
3Y total return
+11.2%
S&P 500 3Y: n/a
5Y total return
+282.5%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns LON/0RV2?

Insider, institutional, and short-interest positioning.

Institutional ownership
+43.7%
Share of float held by funds and institutions
Insider ownership
+32.2%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+0.2%
Negative means the company is buying back shares.
Technical

LON/0RV2 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
46.5
Neutral momentum band
Price vs 200-day MA
+6.5%
50/200-day relationship not available
Beta (5Y)
-0.78
Less volatile than the market
Sharpe ratio
1.21
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About LON/0RV2

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0RV2 stock rating?

lon/0RV2 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0RV2 analysis?

The full report lives at /stocks/lon/0RV2/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0RV2?

The latest report frames lon/0RV2 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0RV2 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.